跳至主要内容
临床试验/NCT01108419
NCT01108419已完成不适用

Evaluation of the Safety and Tolerance of a New Fermented Food in Healthy Adults

Danone Research2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2010年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
96
试验地点
2
主要终点
Effect of 1 bottle/day of test versus control product on kidney function.

研究概览

简要总结

The aim of the study is to assess the safety and tolerance of a new fermented food versus a control product in healthy adults during the 4-week consumption period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects after receiving a full description of the study, provide written informed consent to take part in the study.
  • Free-living subject, as evaluated during the clinical examination.
  • Male/female subjects aged between 18 to 55 years (bounds included).
  • Subjects with a body mass index (BMI) between 18.5 ≤ BMI < 30kg/m².
  • Healthy subjects (as determined by a medical examination)

排除标准

  • Subjects with any allergy (food, respiratory...).
  • Subjects that have had any surgery or intervention requiring general anaesthesia in the last 4 weeks.
  • Subjects with a history of chronic metabolic or gastrointestinal disease with the exception of appendectomy.
  • Subjects with chronic or iatrogenic immunodeficiency (e.g. Chemotherapy, HIV).
  • Subjects presenting a severe evolutive or chronic pathology (e.g. cancer,tuberculosis, Crohn's disease, cirrhosis, multiple sclerosis, Type I diabetes...).
  • Subject with eating disorders.
  • Subjects with cardiac, respiratory (including asthma) or renal insufficiency, cardiomyopathy, valvulopathy and medical history of rheumatic fever.
  • Subjects with special medicated diet (for obesity, anorexia, metabolic pathology...).
  • For female subjects: pregnancy, breast-feeding or not willing to use/not using an acceptable method of contraception
  • Subject, in the Investigator's opinion, should not be randomised.

结局指标

主要结局

Effect of 1 bottle/day of test versus control product on kidney function.

时间窗: During the 4-week period of product consumption.

Blood creatinin (μmol/L).

Effect of 1 bottle/day of test versus control product on blood marker of inflammation.

时间窗: During the 4-week period of product consumption.

Blood C-reactive protein (mmol/L)

Effect of 1 bottle/day of test versus control product on bowel habits.

时间窗: During the 4-week period of product consumption.

Stool frequency and consistency (Bristol Stool Scale from 1 \[hard stools\] to 7 \[watery stools\]).

Effect of 1 bottle/day of test versus control product on glucose and lipids metabolism.

时间窗: During the 4-week period of product consumption.

blood glucose (mmol/L), lipids \[total cholesterol, HDL, LDL, triglycerides\] (mmol/L).

Effect of 1 bottle/day of test versus control product on liver function.

时间窗: During the 4-week period of product consumption.

Blood alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltransferase (IU/L).

Effect of 1 bottle/day of test versus control product on digestive symptoms.

时间窗: During the 4-week period of product consumption.

Frequency of abdominal pain/discomfort, abdominal bloating, flatulence, borborygmi/rumbling.

Effect of 1 bottle/day of test versus control product on adverse events.

时间窗: During the 4-week period of product consumption.

Number of Adverse events, number of AE related to product, number of emergent AE, number of mild/moderate and severe AE, number of serious AE.

Effect of 1 bottle/day of test versus control product on thyroid function.

时间窗: During the 4-week period of product consumption.

Blood thyroid stimulating hormone (mU/L).

Effect of 1 bottle/day of test versus control product on fecal marker of inflammation.

时间窗: During the 4-week period of product consumption.

Fecal calprotectin (μg/g)

Effect of 1 bottle/day of test versus control product vital signs.

时间窗: During the 4-week period of product consumption.

Systolic/diastolic blood pressure (mmHg).

Effect of 1 bottle/day of test versus control product on hematology.

时间窗: During the 4-week period of product consumption.

Hemoglobin (mmol/L).

次要结局

  • Effect of 1 bottle/day of test versus control product on liver function.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on kidney function.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on blood marker of inflammation.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on bowel habits.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on adverse events.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on glucose and lipids metabolism.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on fecal marker of inflammation.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on digestive symptoms.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on kidney function.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on thyroid function.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on thyroid function.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on liver function.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on fecal marker of inflammation.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on test product strains detection and quantification in feces.(During the 4-week period of product consumption and after 4-week follow-up period.)
  • Effect of 3 bottles/day of test versus control product on test product strains detection and quantification in feces.(During the 4-week period of product consumption and after 4-week follow-up period.)
  • Effect of 3 bottles/day of test versus control product on blood marker of inflammation.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on adverse events.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on bowel habits.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on digestive symptoms.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on glucose and lipids metabolism.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on microbiota analysis in feces.(During the 4-week period of product consumption and after 4-week follow-up period.)
  • Effect of 1 bottle/day of test versus control product vital signs.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on hematology.(During the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product vital signs.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 3 bottles/day of test versus control product on hematology.(During the 4-week period of product consumption, the 4-week follow-up period and the 8-week entire study period.)
  • Effect of 1 bottle/day of test versus control product on microbiota analysis in feces.(During the 4-week period of product consumption and after 4-week follow-up period.)

研究者

发起方
Danone Research
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验